BRISTOL MYERS SQUIBB CO (BMY)
@BMY.asset
$46.02
At close:
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.
Figures
- Sector Healthcare
- Industry Drug Manufacturers
- Index S&P 500
- Market Cap $93.69 B
- Last Earnings Report Oct 30, 2025
- Price Reaction to Earnings Report 8.04%
- Enterprise Value $125.80 B
- Dividend Yield 0.05%
- P/E ratio 15.49
- Price/Sales ratio 1.95
- EV/Sales ratio 2.62
- Price/Book Value 5.03
- Revenue $48.03 B
- EBIT $0.00 B
- Net Income $6.04 B
- Gross Profit $33.38 B
- Free Cash Flow $15.17 B
- EBIT Margin ?%
- Gross Margin 69.50%
- FCF Margin 31.59%
- Return on Equity 32.46%
- Equity Ratio 19.20%
- Debt/Equity Ratio 4.21
- 6-month Performance -5.58%
- 12-month Performance -11.06%
- Trend reversal neutral
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |